← All Sponsors
SPONSOR

Ascletis Pharma (China) Co., Limited

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Plaque Psoriasis

Ascletis Pharma (China) Co., Limited is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Plaque Psoriasis.

The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Ascletis Pharma (China) Co., Limited

How many clinical trials has Ascletis Pharma (China) Co., Limited sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Ascletis Pharma (China) Co., Limited, of which 1 are actively recruiting participants. These trials cover conditions including Plaque Psoriasis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Ascletis Pharma (China) Co., Limited research focus on?
Ascletis Pharma (China) Co., Limited clinical trials span Plaque Psoriasis. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Ascletis Pharma (China) Co., Limited clinical trial?
To participate in a Ascletis Pharma (China) Co., Limited trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Ascletis Pharma (China) Co., Limited trials with current recruitment status updated daily.

Clinical Trials by Ascletis Pharma (China) Co., Limited

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology